| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 1TG15H1XE9 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | Amyloid-beta A4 protein binding agent |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cerebral Amyloid Angiopathy | 2 | D016657 | ClinicalTrials |
| Alzheimer Disease | 2 | D000544 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1178862-65-1 |
| ChEMBL | CHEMBL1743058 |
| FDA SRS | 1TG15H1XE9 |
CONTENTS